SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-074311
Filing Date
2018-12-21 11:45:20
Period of Report
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41911_18k.htm 8-K 74155
2 EX-3.1 a18-41911_1ex3d1.htm EX-3.1 11898
3 EX-3.2 a18-41911_1ex3d2.htm EX-3.2 64314
4 EX-10.2 a18-41911_1ex10d2.htm EX-10.2 22356
5 GRAPHIC g419111kmi001.jpg GRAPHIC 6498
  Complete submission text file 0001104659-18-074311.txt   183491
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35050 | Film No.: 181248287
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences